Industry News

Industry News

Significant Breakthrough Has Implications For Throat And Cervical Cancer

Aug 10, 2012

A major breakthrough by scientists at Queen's could lead to more effective treatments for throat and cervical cancer. The discovery could see the development of new therapies, which would target the non-cancerous cells surrounding a tumour, as well as treating the tumour itself... Read More

Using Heat As A Cancer Treatment

Aug 10, 2012

Research at Bangor University has identified a switch in cells that may help to kill tumors with heat. Prostate cancer and other localized tumors can be effectively treated by a combination of heat and an anti-cancer drug that damages the genes. Behind this novel therapy is the enigmatic ability of heat to switch off essential survival mechanisms in human cells... Read More

Scientists Find A Breakthrough Method Of Improving Chemotherapy

Aug 09, 2012

Even though chemotherapy kills tumor cells, it also causes damage to the rest of the body. However, a team of researchers from South Carolina's College of Pharmacy has now discovered a new class of drugs that can decrease the adverse effects that chemotherapy causes in cellular damage... Read More

Scientists Find A Breakthrough Method Of Improving Chemotherapy

Aug 09, 2012

Even though chemotherapy kills tumor cells, it also causes damage to the rest of the body. However, a team of researchers from South Carolina's College of Pharmacy has now discovered a new class of drugs that can decrease the adverse effects that chemotherapy causes in cellular damage... Read More

First Patient Enrolled In A Clinical Study With CP-4126 In Combination With Cisplatin In Non-Small Cell Lung Cancer

Aug 09, 2012

Clavis Pharma ASA (OSE: CLAVIS), the Norwegian cancer drug development company, announces that a Phase I study of CP-4126 (CO-101) in combination with cisplatin in non-small-cell lung cancer (NSCLC) has been initiated by its partner Clovis Oncology. The first patient has now been dosed in this two-part study, which is being conducted at cancer centres in the USA and the UK... Read More

First Patient Enrolled In A Clinical Study With CP-4126 In Combination With Cisplatin In Non-Small Cell Lung Cancer

Aug 09, 2012

Clavis Pharma ASA (OSE: CLAVIS), the Norwegian cancer drug development company, announces that a Phase I study of CP-4126 (CO-101) in combination with cisplatin in non-small-cell lung cancer (NSCLC) has been initiated by its partner Clovis Oncology. The first patient has now been dosed in this two-part study, which is being conducted at cancer centres in the USA and the UK... Read More

No Proven Benefit For PET And PET/CT In Ovarian Cancer

Aug 09, 2012

Only in certain cases are recurrences detected more reliably than with conventional techniques Due to the lack of studies, there is currently no proof that patients with ovarian cancer can benefit from positron emission tomography (PET) alone or in combination with computed tomography (CT)... Read More

Extending Vaccination Against Human Papilloma Virus To Young Men?

Aug 09, 2012

Vaccination against human papilloma virus (HPV) is recommended for young women to protect them from HPV infection and cervical cancer. Male HPV immunization is increasingly a topic of debate in the medical community. A timely review of the literature published in Viral Immunology, a peer-reviewed journal from Mary Ann Liebert, Inc... Read More

No Proven Benefit For PET And PET/CT In Ovarian Cancer

Aug 09, 2012

Only in certain cases are recurrences detected more reliably than with conventional techniques Due to the lack of studies, there is currently no proof that patients with ovarian cancer can benefit from positron emission tomography (PET) alone or in combination with computed tomography (CT)... Read More

"Pancreas In A Dish" Helps Scientists Study How Pancreatic Cancer Forms

Aug 09, 2012

A tiny, living 3-D organ model of pancreatic ducts has been created by researchers in Toronto to help them understand pancreatic cancer, which is one of the deadliest yet least understood of all cancers. This new model could lead to the discovery of new ways to detect and treat pancreatic cancer... Read More

Previous Page   Next Page